Duality Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Duality Advisers’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-170,737	Closed	-$1.67M	–	864
2021 Q4	$1.67M	Buy	170,737 +145,306	+571%	+$2.73M	0.18%	207
2021 Q3	$864K	Buy	25,431 +19,621	+338%	+$626K	0.07%	382
2021 Q2	$213K	Sell	5,810 -10,194	-64%	-$395K	0.02%	503
2021 Q1	$718K	Sell	16,004 -15,637	-49%	-$728K	0.06%	400
2020 Q4	$1.81M	Buy	+31,641	New	+$1.88M	0.13%	239

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Duality Advisers's DCPH Position: Q1 2022 in Review

Duality Advisers sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 170,737 shares — an estimated $1.67M sold.

Duality Advisers first reported a position in DCPH in Q4 2020 and held it in 5 quarters. The position peaked at $1.81M in Q4 2020. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Duality Advisers reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Duality Advisers sold 170,737 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $1.67M.
Duality Advisers first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Duality Advisers's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.81M in Q4 2020.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Duality Advisers's 13F filing for Q1 2022, filed 9 May 2022.